Connection

Gavin Screaton to Pandemics

Back to Details
This is a "connection" page, showing publications Gavin Screaton has written about Pandemics.
Gavin Screaton
Connection Strength
0.032
Pandemics
  1. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 04 15; 184(8):2201-2211.e7.
    View in: PubMed
    Score: 0.008
  2. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020. Euro Surveill. 2020 10; 25(42).
    View in: PubMed
    Score: 0.008
  3. SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020. Euro Surveill. 2020 10; 25(42).
    View in: PubMed
    Score: 0.008
  4. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021 04 06; 12(1):2055.
    View in: PubMed
    Score: 0.002
  5. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020 11; 21(11):1336-1345.
    View in: PubMed
    Score: 0.002
  6. Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study. Elife. 2020 08 21; 9.
    View in: PubMed
    Score: 0.002
  7. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat Struct Mol Biol. 2020 10; 27(10):950-958.
    View in: PubMed
    Score: 0.002
  8. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe. 2020 09 09; 28(3):445-454.e6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.